A phase II, multicentre, randomised, double-blind, parallel groups, placebo controlled clinical study of efficacy and safety of Dysport [botulinum toxin A] for migraine prophylaxis.
Phase of Trial: Phase II
Latest Information Update: 19 Nov 2009
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Ipsen
- 12 Sep 2007 Status changed from in progress to completed.
- 05 Nov 2006 New trial record.